Risk Factors and Predictors of Cardiac Erosion Discovered from 12 Japanese Patients Who Developed Erosion After

Masataka Kitano1, Satoshi Yazaki2, Hisashi Sugiyama3

  • 1Department of Pediatric Cardiology, National Cerebral and Cardiovascular Center, 6-1, Kishibeshinmachi, Suita City, Osaka Prefecture, 564-8565, Japan. kitanom@ncvc.go.jp.

Pediatric Cardiology
|November 17, 2019
PubMed

Insights

Cardiac erosion after Amplatzer septal occluder (ASO) placement is rare but serious. A deeper Valsalva sinus wall deformation, measured as Dent, predicts erosion risk, suggesting device adjustment if Dent exceeds 2.0 mm.

Area of Science:

  • Cardiology
  • Medical Devices
  • Echocardiography

Background:

  • Cardiac erosion is a rare but severe complication post-Amplatzer septal occluder (ASO) implantation for atrial septal defects.
  • Existing risk factors for erosion are insufficient for effective prevention.
  • Predictive markers for post-procedural cardiac erosion remain elusive.

Purpose of the Study:

  • To identify a reliable predictor for cardiac erosion following ASO placement.
  • To evaluate the significance of Valsalva sinus wall deformation (Dent) as a risk factor.
  • To establish criteria for device adjustment to prevent erosion.

Main Methods:

  • Retrospective analysis of 12 patients with cardiac erosion post-ASO placement (2005-2016).
  • Comparison of patient characteristics and transesophageal echocardiography findings with 95 control patients without erosion.
  • Measurement of Valsalva sinus wall deformation (Dent) immediately after ASO placement.

Main Results:

  • The mean Dent measurement was significantly deeper in patients who developed erosion (2.48 mm) compared to those who did not (1.28 mm) (p < 0.001).
  • Erosion occurred at the atrial roof, often where the device disk edge pressed the Valsalva wall.
  • No significant differences were observed in other previously identified risk factors between the groups.

Conclusions:

  • Dent, a measure of Valsalva sinus wall deformation, is a significant predictor of cardiac erosion after ASO placement.
  • A Dent measurement greater than 2.0 mm warrants consideration for device size change or replacement.
  • This finding offers a potential strategy to mitigate the risk of cardiac erosion.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
336
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
350
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
227
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
240